跳至主要内容
临床试验/NCT00002670
NCT00002670已完成3 期

Phase III Intergroup Trial of Surgery Followed by (1) Radiotherapy vs. (2) Radiochemotherapy For Resectable High Risk Squamous Cell Carcinoma of the Head and Neck

Radiation Therapy Oncology Group23 个研究点 分布在 2 个国家目标入组 459 人开始时间: 1995年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
459
试验地点
23

研究概览

简要总结

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy plus cisplatin is more effective than radiation therapy alone in treating patients with head and neck cancer.

PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy plus cisplatin with radiation therapy alone in treating patients with head and neck cancer that has been removed during surgery.

详细描述

OBJECTIVES: I. Evaluate locoregional control rates, patterns of first failure, and overall and disease-free survival in patients with advanced squamous cell carcinoma of the head and neck at high risk of locoregional recurrence who are treated postoperatively with concurrent cisplatin and radiotherapy. II. Compare the toxicity of concurrent chemoradiotherapy vs. radiotherapy alone in the postoperative setting.

OUTLINE: Randomized study. Arm I: Radiotherapy. Involved-field irradiation using Co60, 1-6 MV photons, or electrons. Arm II: Radiotherapy plus Single-Agent Chemotherapy. Irradiation as in Arm I; plus Cisplatin, CDDP, NSC-119875.

PROJECTED ACCRUAL: 438 patients will be entered over approximately 5 years.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Radiation therapy plus cisplatin

Experimental

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week) plus Cisplatin-100 mg/m2 i.v. on days 1,22 and 43 with radiation therapy.

干预措施: low-LET electron therapy (Radiation)

Radiation therapy

Active Comparator

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week)

干预措施: low-LET cobalt-60 gamma ray therapy (Radiation)

Radiation therapy

Active Comparator

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week)

干预措施: low-LET electron therapy (Radiation)

Radiation therapy

Active Comparator

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week)

干预措施: low-LET photon therapy (Radiation)

Radiation therapy plus cisplatin

Experimental

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week) plus Cisplatin-100 mg/m2 i.v. on days 1,22 and 43 with radiation therapy.

干预措施: chemotherapy (Drug)

Radiation therapy plus cisplatin

Experimental

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week) plus Cisplatin-100 mg/m2 i.v. on days 1,22 and 43 with radiation therapy.

干预措施: cisplatin (Drug)

Radiation therapy plus cisplatin

Experimental

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week) plus Cisplatin-100 mg/m2 i.v. on days 1,22 and 43 with radiation therapy.

干预措施: low-LET cobalt-60 gamma ray therapy (Radiation)

Radiation therapy plus cisplatin

Experimental

Radiation therapy - 60 Gy in 6 weeks (2 Gy once a day, 5 x a week) plus Cisplatin-100 mg/m2 i.v. on days 1,22 and 43 with radiation therapy.

干预措施: low-LET photon therapy (Radiation)

研究者

申办方类型
Network
责任方
Sponsor

研究点 (23)

Loading locations...

相似试验